2023
DOI: 10.1080/14712598.2023.2185510
|View full text |Cite
|
Sign up to set email alerts
|

Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn’s disease: results from an Italian multicenter study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 54 publications
0
1
0
Order By: Relevance
“…(5-ASAs) [5]. Patients with UC often are undertreated because of the possibility of curative colectomy and the perception that the disease burden is lower than that of CD.…”
Section: Introductionmentioning
confidence: 99%
“…(5-ASAs) [5]. Patients with UC often are undertreated because of the possibility of curative colectomy and the perception that the disease burden is lower than that of CD.…”
Section: Introductionmentioning
confidence: 99%